Newly diagnosed patients with cancer at increased risk for stroke
the ONA take:
According to a new study published in the journal Annals of Neurology, researchers at Weill Cornell Medical College in New York City, New York, have found that newly diagnosed patients with cancer, particularly those with more aggressive disease, are at an increased risk for stroke in the months following diagnosis.
For the study, researchers analzyed Medicare claims from 2001 to 2009 by patients who had been diagnosed with colorectal, prostate, breast, lung, and pancreatic cancer. Results showed that compared to seniors without cancer, those with cancer had a much risk for stroke, especially during the first 3 months following cancer diagnosis.
Patients with colorectal, lung, and pancreatic cancer had the highest risk of stroke, as those diseases are often more aggressive at the time of diagnosis. Those with breast and prostate cancer had the lowest risk for stroke as those diseases are typically diagnosed as localized tumors.
Although the study was not designed to determine why patients with cancer have an increased risk for stroke, the researchers suggest that cancer and the treatments for cancer affect the circulatory and coagulation systems. The researchers note that patients should be advised of the signs and symptoms of stroke as it can delay cancer treatment and cause disability and death.
Newly diagnosed patients with cancer are at an increased risk for stroke in the months following diagnosis.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|